F Tagliaferri1, I Sirovich, F Stipa
1Cattedra di Chirurgia, Università La Sapienza, Roma.
Immunotherapy using tumor-associated antigens shows promise for treating solid tumors as an adjuvant to surgery. Clinical trials indicate potential benefits in survival and progression-free intervals, suggesting a future role in oncology.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: